Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genistein Aglycone in Glucocorticoid Induced Osteoporosis
NCT03040531Phase 3Unknown
- Sponsor
- University of Messina
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by University of Messina. Primary endpoints: Bone Mineral Density at 24 months, Bone Fracture at 24 months and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT03040531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03040531.